Legal & General Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,514
| Closed | -$62.5K | – | 3408 |
|
|
2024
Q4 | $62.5K | Sell |
6,514
-106
| -2% | -$1.02K | ﹤0.01% | 2755 |
|
|
2024
Q3 | $18.9K | Hold |
6,620
| – | – | ﹤0.01% | 3071 |
|
|
2024
Q2 | $19.3K | Buy |
6,620
+480
| +8% | +$1.4K | ﹤0.01% | 3032 |
|
|
2024
Q1 | $19.6K | Hold |
6,140
| – | – | ﹤0.01% | 2969 |
|
|
2023
Q4 | $20.6K | Sell |
6,140
-411
| -6% | -$1.38K | ﹤0.01% | 3021 |
|
|
2023
Q3 | $15.6K | Hold |
6,551
| – | – | ﹤0.01% | 3125 |
|
|
2023
Q2 | $11.5K | Buy |
+6,551
| New | +$11.5K | ﹤0.01% | 3296 |
|
|
2022
Q2 | – | Sell |
-2,310
| Closed | -$10K | – | 3690 |
|
|
2022
Q1 | $10K | Hold |
2,310
| – | – | ﹤0.01% | 3411 |
|
|
2021
Q4 | $16K | Hold |
2,310
| – | – | ﹤0.01% | 3354 |
|
|
2021
Q3 | $17K | Hold |
2,310
| – | – | ﹤0.01% | 3338 |
|
|
2021
Q2 | $23K | Sell |
2,310
-1,073
| -32% | -$10.7K | ﹤0.01% | 3252 |
|
|
2021
Q1 | $32K | Buy |
3,383
+1,917
| +131% | +$18.1K | ﹤0.01% | 2973 |
|
|
2020
Q4 | $16K | Hold |
1,466
| – | – | ﹤0.01% | 3184 |
|
|
2020
Q3 | $13K | Buy |
+1,466
| New | +$13K | ﹤0.01% | 3140 |
|